Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gavras

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Journal of Human Hypertension|April 3, 2009
Angiotensin inhibition and malignancies: a reviewT Rosenthal, I Gavras
Clinical Cardiology|August 1, 1991
Cardioprotective potential of angiotensin-converting enzyme inhibitorsI Gavras, H Gavras
American Journal of Hypertension|May 29, 2000
The antiarrhythmic potential of angiotensin II antagonism: experience with losartanI Gavras, H Gavras
Annals of Internal Medicine|April 1, 1983
Captopril and enalaprilI Gavras, H Gavras
Recent Progress in Hormone Research|October 14, 1998
Salt in hypertension: physiological and molecular aspectsI Gavras, H Gavras
Journal of Hypertension|May 1, 1991
Cardioprotective potential of angiotensin converting enzyme inhibitorsH Gavras, I Gavras
American Journal of Hypertension|June 20, 2001
Role of alpha2-adrenergic receptors in hypertensionI Gavras, H Gavras
Hospital Practice (Office Ed.)|July 15, 1993
ACE inhibitors: a decade of clinical experienceI Gavras, H Gavras
American Family Physician|April 29, 1998
The calcium channel antagonist controversyI Gavras, H Gavras
Journal of Hypertension|November 1, 1991
Angiotensin converting enzyme inhibitorsH Gavras, I Gavras
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Journal of Human Hypertension|April 3, 2009
Angiotensin inhibition and malignancies: a reviewT Rosenthal, I Gavras
Clinical Cardiology|August 1, 1991
Cardioprotective potential of angiotensin-converting enzyme inhibitorsI Gavras, H Gavras
American Journal of Hypertension|May 29, 2000
The antiarrhythmic potential of angiotensin II antagonism: experience with losartanI Gavras, H Gavras
Annals of Internal Medicine|April 1, 1983
Captopril and enalaprilI Gavras, H Gavras
Recent Progress in Hormone Research|October 14, 1998
Salt in hypertension: physiological and molecular aspectsI Gavras, H Gavras
Journal of Hypertension|May 1, 1991
Cardioprotective potential of angiotensin converting enzyme inhibitorsH Gavras, I Gavras
American Journal of Hypertension|June 20, 2001
Role of alpha2-adrenergic receptors in hypertensionI Gavras, H Gavras
Hospital Practice (Office Ed.)|July 15, 1993
ACE inhibitors: a decade of clinical experienceI Gavras, H Gavras
American Family Physician|April 29, 1998
The calcium channel antagonist controversyI Gavras, H Gavras
Journal of Hypertension|November 1, 1991
Angiotensin converting enzyme inhibitorsH Gavras, I Gavras
Pageof 17